Cargando…
PON-1 carbamylation is enhanced in HDL of uremia patients
High-density lipoprotein (HDL) carbamylation has been known in uremia patients. Paraoxonase-1 (PON-1) is an important HDL protein responsible for HDL anti-oxidant, arylesterase and lactonase activities. PON-1 carbamylation in uremic HDL has never been explored. We isolated HDL from uremia patients a...
Autores principales: | Chang, Chiz-Tzung, Lim, Yun-Ping, Lee, Chi-Wen, Liao, Hsin-Yi, Chen, Feng-Yu, Chang, Chia-Ming, Tang, Feng-Yao, Yang, Chao-Yuh, Chen, Chao-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296198/ https://www.ncbi.nlm.nih.gov/pubmed/30987726 http://dx.doi.org/10.1016/j.jfda.2018.09.007 |
Ejemplares similares
-
Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis
por: Chang, Chiz-Tzung, et al.
Publicado: (2016) -
Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis
por: Chang, Chiz-Tzung, et al.
Publicado: (2017) -
Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012) -
Quantifying PON1 on HDL with nanoparticle-gated electrokinetic membrane sensor for accurate cardiovascular risk assessment
por: Kumar, Sonu, et al.
Publicado: (2023) -
Urine proteome analysis by C(18) plate–matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy
por: Chen, Chao-Jung, et al.
Publicado: (2018)